GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adocia (STU:A89) » Definitions » 3-Year EBITDA Growth Rate

Adocia (STU:A89) 3-Year EBITDA Growth Rate : 15.30% (As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Adocia 3-Year EBITDA Growth Rate?

Adocia's EBITDA per Share for the six months ended in Jun. 2024 was €-0.56.

During the past 3 years, the average EBITDA Per Share Growth Rate was 15.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Adocia was 46.30% per year. The lowest was -41.40% per year. And the median was -2.40% per year.


Competitive Comparison of Adocia's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Adocia's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adocia's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adocia's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Adocia's 3-Year EBITDA Growth Rate falls into.



Adocia 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Adocia  (STU:A89) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Adocia 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Adocia's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Adocia Business Description

Industry
Traded in Other Exchanges
Address
115 Avenue Lacassagne, Lyon, FRA, 69003
Adocia is a clinical-stage biotechnology company. It specializes in the development of formulations of already approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases. The firm has developed Biochaperone, a proprietary technology platform to enhance the effectiveness of therapeutic proteins. The company's clinical pipeline includes Biochaperone Lispro, Biochaparone Combo, Biochaparone Glucagon, and others. Its pre-clinical pipeline includes BioChaperone LisPram, BioChaperone Glargine GLP-1, and BioChaperone Glucagon GLP1. Its patent portfolio mainly consists of chronic wound healing, insulin therapy, and monoclonal antibodies.

Adocia Headlines

No Headlines